CD47 and cancer: Targeting CD47 on cancer cells,158 which binds with the SIRPα myeloid inhibitory receptor expressed on myeloid cells and makes them unresponsive against cancer cells,159, 160 is a novel way of rescuing phagocytic abilities of TAMs (Figure 3A).